Earnings calendar

BeOne Medicines AG (ONC) earnings: date, estimates, results and stock reactions

Over the last 12 reports the stock moved 4.4% on average (either way), rising 6 times and falling 6. EPS beat estimates 7 of 10 times; revenue 5 of 8. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).

QuarterReportedEPSEPS estimateEPS surpriseRevenueRevenue estimateStock move
Q3 FY20262026-11-054.592.34+96.2%1.89B1.75B+7.7%
Q2 FY20262026-08-052.051.63+25.8%1.71B1.62B+2.1%
Q1 FY20262026-05-061.960.73+168.5%1.51B1.44B+6.6%
Q4 FY20252026-02-260.581.60-63.8%1.50B1.47B-10.0%
Q3 FY20252025-11-061.090.72+51.4%1.41B1.45B-0.4%
Q2 FY20252025-08-060.840.48+75.0%1.32B1.44B-2.9%
Q1 FY20252025-05-071.22-0.71+271.8%1.12B1.25B-2.4%
Q4 FY20242025-02-27-1.43-0.88-62.5%1.13B1.04B+4.9%

ONC stock report · Earnings calendar